Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ledda

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Blood Cancer Journal|November 26, 2013
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II studyM Offidani, L Corvatta, L Maracci, et al.
Angiology|August 26, 2000
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European StudyG Belcaro, A N Nicolaides, G Cipollone, et al.
Angiology|August 26, 2000
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trialG Belcaro, A N Nicolaides, G Agus, et al.
Angiology|May 5, 2007
Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion documentM R Cesarone, G Belcaro, G Agus, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Blood Cancer Journal|November 26, 2013
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II studyM Offidani, L Corvatta, L Maracci, et al.
Angiology|August 26, 2000
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European StudyG Belcaro, A N Nicolaides, G Cipollone, et al.
Angiology|August 26, 2000
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trialG Belcaro, A N Nicolaides, G Agus, et al.
Angiology|May 5, 2007
Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion documentM R Cesarone, G Belcaro, G Agus, et al.
Pageof 12